PBH
Prestige Consumer Healthcare Inc.
NYSE · Healthcare · Medical - Distribution · US
$52.26
−0.57%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
11.1x
EV/EBITDA
14.2x
Market Cap
$2.48B
MomentumView details →
1D Return
−0.57%
YTD Return
−15.36%
RSI (14)
52.8
ValuationView details →
P/E (Fwd)
11.1x
EV/EBITDA
14.2x
Market Cap
$2.48B
RSI (14)
52.8
MomentumView details →
1D Return
−0.57%
YTD Return
−15.36%
SummaryUpdated Jun 1, 2026
Prestige Consumer Healthcare Inc. (NYSE:PBH) is a consumer healthcare company founded in 1996 and headquartered in Tarrytown, New York. The company develops, manufactures, markets, and distributes over-the-counter (OTC) health and personal care products primarily in the United States and internationally. Originally known as Prestige Brands Holdings Inc., the company changed its name to Prestige Consumer Healthcare Inc. in August 2018 and went public in February 2005. Today, Prestige operates as a diversified portfolio company with a collection of trusted consumer healthcare brands spanning multiple therapeutic categories.
Similar companies
Latest newsMore news →
Prestige Brand Holdings recalled 39,060 bottles of Clear Eyes eye drops nationwide due to possible contamination and sterility concerns, as reported by the FDA.14d agoPrestige Consumer Healthcare Inc. issued $400.0 million of 6.250% Senior Notes due 2034, with interest payable semi-annually starting January 15, 2027, and maturity on July 15, 2034.52d ago